BGI Diagnosis (short for Shenzhen BGI Diagnosis Technology Co., Ltd.), a subsidiary of BGI, is a clinical medicine platform built to use human genome research results for health relying on the cutting-edge technologies of BGI. With comprehensive coverage of the “4P medicine” practice (Predictive, Preventive, Participatory and Personalized), it is committed to build genetic testing standards and promote clinical application of genetic technology so as to reduce birth defects and preventing major diseases.
With the high-throughput sequencing device, mass spectrometer and high-performance informatics center, BGI Diagnosis has developed advanced genetic testing techniques for a number of diseases such as Down's syndrome and other chromosomal disorders, monogenic disorder, hereditary deafness, thalassemia, newborn genetic metabolic diseases, leukemia, cervical cancer and hepatitis; it also has developed the genetic testing and diagnostic technology system covering life cycle and features significant advantages in sensitivity, accuracy and safety.
Headquartered in Shenzhen, BGI Diagnosis has set up business centers throughout Europe, America and Asia-Pacific with service network around the world. So far, it has erated with many domestic and international medical organizations to provide high quality testing services.

Mission

1)To serve the wellbeing of human with the high-throughput, cost effective, omics platform.

2)Be the world’s leader in healthcare, establish industrial standard, using “Big Data” to serve “Big” Science and provide “Population-based” healthcare solution.

For more information, please visit Official Website of BGI Diagnosis 

Qualification and Certification

   




Medical Institutions Practicing License for Shenzhen BGI Unicare Clinic
Medical Institutions Practicing License for Wuhan BGI Medical Laboratory
Medical Institutions Practicing License for Medical Laboratory of Tianjin BGI Technology Co., Ltd

             

Certifications of Next Generation Sequencing Diagnostic Products(CFDA Arppoved)

Cooperative Agencies

Headquartered in Shenzhen, BGI Diagnosis cooperates with over 1000 leading hospitals in the world, including Americas, Europe, Asia Pacific, Japan, Hong Kong, and Beijing, Tianjin, Shanghai, Hangzhou, Wuhan, Guangzhou of mainland China.